Article
12 Sep 2025
DTC Reforms And MAHA Proclamations: The MAHA Agenda And Its Focus On Prescription Drugs Continues To Take Shape
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
11 Sep 2025
Transparency So Radical It Overlooks Law And Tradition: FDA Releases Complete Response Letters For Unapproved Drugs
Article
25 Aug 2025
The Demise Of FDA's Administrative Summary Judgment Standard: Lessons From Vanda v. FDA
Article
12 Aug 2025
FDA Okays Continued PFAS Use In Medical Devices: Says Unlikely To Cause Harm
Article
04 Apr 2025
LDTs Are Not Devices Under The FDCA: Eastern District Of Texas Vacates FDA Final Rule On LDTs
Article
20 Feb 2025
A First Look At The MAHA Era: Initial Thoughts For Industry Based On The MAHA Commission EO
Article
18 Feb 2025
The DOGE Workforce Optimization EO: Implications For FDA
Article
03 Feb 2025
Late Guidance Push By Biden Administration Over Clinical Trial Diversity Faces New Obstacles From Recent Trump Executive Orders
Article
30 Jan 2025
FDA Finalizes Rule On ACNU Drugs, Signaling Opening For Next-Gen OTC Drugs
Article
09 Dec 2024
LDT Final Rule Litigation — Status Of Pending Court Challenges And What May Happen Next